查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
無血清市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按介質類型、終端用戶、公司和地區分類
市場調查報告書
商品編碼
1289658

無血清市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測，按介質類型、終端用戶、公司和地區分類

Serum Free Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Media Type, By End User, By company and By Region
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2023-2027年的預測期內，全球無血清市場預計將出現令人矚目的成長。主要因素包括傳染病和慢性病的流行率上升，癌症治療對細胞療法的需求，以及研發活動的增加，這些都推動了市場的成長。無血清培養基是用於在沒有血清的情況下生長特定的細胞類型或執行特定的應用的培養基。無血清培養基（SFM）的使用標誌著一種重要的工具，它使細胞培養能夠在一套確定的條件下進行，並儘可能不存在混雜的變量。支持市場成長的其他因素是，對各種重組蛋白和培養類型的需求不斷增加，罕見疾病的患者登記不斷擴大，下游處理更加容易，開發新型治療藥物的研究和開發不斷增加，生物製藥行業和生物製藥生產的擴大，採用先進技術，以及研究和開發活動的增加。此外，不斷增加的戰略成長，如合併、合作和收購，正在加強市場的成長。例如，在2019年，Sartorius宣布收購細胞培養基專家生物公司的大部分股份。

傳染病和慢性病的發病率不斷上升

心血管疾病、糖尿病、性病、呼吸道感染和院內感染等傳染病和慢性病的發病率上升，正在推動全球市場的成長。由於生活方式的改變、社會行為和不健康的飲食選擇，人們正在遭受這些疾病的困擾，這推動了市場的成長。根據世界衛生組織（WHO）的數據，傳染病每年造成約1700萬人死亡。老年人群是這些疾病的高發人群，如骨科疾病、流感、心血管疾病、結核病、神經系統疾病和鼻腔內（醫院獲得的）感染。根據國家腎臟基金會的數據，在全球範圍內，65至74歲的人中有四分之一的女性和五分之一的男性患有慢性腎臟病。無血清培養基被用於許多類型的懸浮和粘附培養，以生產免疫細胞，如細胞毒性淋巴細胞（CTL）、IL-2、IL-4和單核細胞，這些細胞被用於生產各種疫苗。

隨著無血清培養基的採用，生物製藥生產不斷增加

由於無血清培養基的特性，如較低的傳染病風險、較少的污染物和較低的干擾成分風險，生物製藥生產的增加和無血清培養基的採用，正在促進市場的成長。由於各種疾病的發病率上升，治療這些疾病的需求也在激增。這要歸功於生物製藥的高效力，這使它們成為治療的選擇，從而增加了生物製藥的生產。因此，生物製藥行業的擴張和生產的增加正在增強市場的成長。例如，在2019年，藥物評價和研究中心批准了48種新藥，其中28%是生物製劑。

可用的定製服務

利用給定的市場數據，TechSci Research根據公司的具體需求提供定製服務。該報告有以下定製選項：

公司資訊

  • 其他市場參與者（最多5家）的詳細分析和概況。

目錄

第一章：產品概述

第二章：研究方法

第三章：執行摘要

第四章：COVID-19對全球無血清媒體市場的影響

第五章：客戶的聲音

第六章：全球無血清培養基市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按介質類型（普通無血清，無異種，化學定義，無蛋白，其他）
    • 按終端用戶（生物技術和製藥公司、學術和研究機構、契約研究機構、其他）分類
    • 按公司分類（2021年）
    • 按地區分類
  • 市場地圖

第七章：北美無血清培養基市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按介質類型
    • 按終端用戶分類
    • 按國家分類
  • 北美洲：國家分析
    • 美國
    • 美國
    • 墨西哥

第8章：歐洲無血清培養基市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按介質類型
    • 按終端用戶分類
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章：亞太地區無血清培養基市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按介質類型
    • 按終端用戶分類
    • 按國家分類
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第十章：南美無血清培養基市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按介質類型
    • 按終端用戶分類
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲無血清培養基市場前景

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按介質類型
    • 按終端用戶分類
    • 按國家分類
  • MEA: 國家分析
    • 南非無血清培養基
    • 沙烏地阿拉伯無血清媒體
    • 阿拉伯聯合大公國無血清媒體

第12章：市場動態

  • 驅動力
  • 挑戰

第十三章：市場趨勢和發展

第十四章：競爭格局（包括SWOT分析）

  • 康寧公司
  • 龍沙集團股份有限公司
  • Merck KgaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • FUJIFILM控股有限公司
  • PromoCell GmbH
  • 雅典娜環境科學公司
  • STEMCELL Technologies Inc.
  • 丹納赫公司
  • 研發系統公司
  • 中國生物製品公司
  • 海明威實驗室有限公司
  • PAN-生物技術有限公司
  • MP Biomedicals, LLC

第十五章：戰略建議

簡介目錄
Product Code: 13046

The global serum-free market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the rising prevalence of infectious and chronic diseases, demand for cell therapies for cancer treatment, and an increase in R&D activities that are impelling the growth of the market. Serum-free media are media intended to grow a specific cell type or execute a specific application in the absence of serum. The use of serum-free media (SFM) signifies an essential tool that enables cell culture to be performed with a defined set of conditions as free as possible of confounding variables. The other factors supporting the market's growth are, increasing demand for various recombinant proteins and types of culture, expanding patient registry for rare diseases, easier downstream processing, growing research & development for the development of novel therapeutic drugs, expansion of biopharmaceutical industries and biopharma production, adoption of advanced technology, and rise in research and development activities. Also, the increasing strategic growth, such as mergers, collaborations, and acquisitions, is strengthening the growth of the market. For instance, in 2019, Sartorius declared the acquisition of a majority stake in cell culture media specialist biological companies.

Rising Prevalence of Infectious and Chronic Diseases

The rising incidences of infectious and chronic diseases such as cardiovascular diseases, diabetes, STD, respiratory infections, and nosocomial (hospital-acquired) infections are bolstering the growth of the market globally. Owing to lifestyle changes, social behavior, and unhealthy eating choices, people are suffering from these diseases, which propels the growth of the market. According to the World Health Organization (WHO), infectious diseases kill around 17 million people a year. Geriatric populations are highly prone to these diseases, such as orthopedic diseases, influenza, cardiovascular diseases, tuberculosis, neurological disorders, and nosocomial (hospital-acquired) infections. According to the National Kidney Foundation, one in four women and one in five men aged between 65 to 74 years have chronic kidney disease across the globe. Serum-free media is used in numerous types of suspension and adherent cultures to produce immunological cells such as cytotoxic lymphocytes (CTLs), IL-2, IL-4, and monocytes, which are utilized in the production of a variety of vaccines.

Increasing Biopharmaceutical Production with the Adoption of Serum-Free Media

The increase in biopharmaceutical production with the rise in adoption of serum-free media, due to its properties such as lower risks of infectious agents, fewer contaminants, and lower risk of interfering components, is facilitating the growth of the market. Owing to the rising incidences of various diseases, the demand to treat these diseases is also surging. This is attributed to the high potency of biopharmaceuticals, which enables them to be the choice of treatment, thus increasing biopharmaceutical production. Thus, the expansion of biopharmaceutical industries and the rise in production are augmenting the growth of the market. For Instance, in 2019, the Center for Drug Evaluation and Research approved 48 new drugs in which, 28% of which were biologics.

Market Segmentation

The global serum-free market is segmented into media type, end user, and company. Based on the media type, the market is segmented into common serum-free, xeno-free, chemically defined, protein-free, and others. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, academic & research organizations, contract research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of research and development and clinical trial programs in the country.

Market Players

Corning Incorporated, Lonza Group AG, Merck KgaA, Sartorius AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, PromoCell GmbH, Athena Environmental Sciences, Inc., STEMCELL Technologies Inc., Danaher Corporation, R&D Systems, Inc., Sino Biological, Inc., HiMedia Laboratories, LLC, PAN-Biotech GmbH, and MP Biomedicals, LLC are some of the leading companies operating in the market.

Report Scope

In this report, global serum-free market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Serum Free Market, By Media Type:

  • Common Serum Free
  • Xeno-Free
  • Chemically Defined
  • Protein-Free
  • Others

Serum Free Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Organizations
  • Contract Research Organizations
  • Others

Serum Free Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Serum Free Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Serum Free Media Market

5. Voice of Customer

6. Global Serum Free Media Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Media Type (Common Serum Free, Xeno-Free, Chemically Defined, Protein-Free, Others)
    • 6.2.2. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Contract Research Organizations, Others)
    • 6.2.3. By Company (2021)
    • 6.2.4. By Region
  • 6.3. Market Map

7. North America Serum Free Media Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Media Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Serum Free Media Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Media Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Canada Serum Free Media Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Media Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Mexico Serum Free Media Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Media Type
        • 7.3.3.2.2. By End User

8. Europe Serum Free Media Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Media Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Serum Free Media Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Media Type
        • 8.3.1.2.2. By End User
    • 8.3.2. Germany Serum Free Media Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Media Type
        • 8.3.2.2.2. By End User
    • 8.3.3. United Kingdom Serum Free Media Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Media Type
        • 8.3.3.2.2. By End User
    • 8.3.4. Italy Serum Free Media Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Media Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Spain Serum Free Media Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Media Type
        • 8.3.5.2.2. By End User

9. Asia-Pacific Serum Free Media Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Media Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Serum Free Media Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Media Type
        • 9.3.1.2.2. By End User
    • 9.3.2. India Serum Free Media Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Media Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Japan Serum Free Media Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Media Type
        • 9.3.3.2.2. By End User
    • 9.3.4. South Korea Serum Free Media Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Media Type
        • 9.3.4.2.2. By End User
    • 9.3.5. Australia Serum Free Media Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Media Type
        • 9.3.5.2.2. By End User

10. South America Serum Free Media Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Media Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Serum Free Media Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Media Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Argentina Serum Free Media Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Media Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Colombia Serum Free Media Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Media Type
        • 10.3.3.2.2. By End User

11. Middle East and Africa Serum Free Media Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Media Type
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Serum Free Media Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Media Type
        • 11.3.1.2.2. By End User
    • 11.3.2. Saudi Arabia Serum Free Media Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Media Type
        • 11.3.2.2.2. By End User
    • 11.3.3. UAE Serum Free Media Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Media Type
        • 11.3.3.2.2. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive SWOT Analysis)

  • 14.1. Corning Incorporated
  • 14.2. Lonza Group AG
  • 14.3. Merck KgaA
  • 14.4. Sartorius AG
  • 14.5. Thermo Fisher Scientific Inc.
  • 14.6. FUJIFILM Holdings Corporation
  • 14.7. PromoCell GmbH
  • 14.8. Athena Environmental Sciences, Inc.
  • 14.9. STEMCELL Technologies Inc.
  • 14.10. Danaher Corporation
  • 14.11. R&D Systems, Inc.
  • 14.12. Sino Biological, Inc.
  • 14.13. HiMedia Laboratories, LLC
  • 14.14. PAN-Biotech GmbH
  • 14.15. MP Biomedicals, LLC

15. Strategic Recommendations